Centro Hospitalar do Porto   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Porto Portugal (2007)

Organization Overview

First Clinical Trial
2009
NCT03961958
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Centro Hospitalar do Porto | Centro Hospitalar S. João, Porto, Portugal | Centro Hospitalar Universitário do Porto

Active Ingredients

Drugs in Phase 4 Trials (2)

rocuronium (zemuron) (1 trial)

sugammadex (bridion) (1 trial)

Drugs in Phase 3 Trials (1)

polidocanol (asclera) (1 trial)

Drugs in Phase 2 Trials (1)

odiparcil (1 trial)

Drugs in Other Trials (6)

desflurane (suprane) (1 trial)

levobupivacaine (chirocaine) (1 trial)

propofol (diprivan) (1 trial)

ropivacaine (naropin) (2 trials)

sevoflurane (ultane) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhoids (Phase 3)

Mucopolysaccharidoses (Phase 2)

Mucopolysaccharidosis VI (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 10